Gabriel Leventhal
CSOPharmaBiomePedro Correa de Sampaio
CEONeobe TherapeuticsRomain Daillere
Head of Preclinical Research, Co-FounderEverimmuneJean-Luc Marsat
CEOEverimmuneAaron Cowley, Ph.D., MBA
Chief Scientific OfficerReciBioPharmBenjamin Hadida
Chief Executive OfficerExeliom BiosciencesOsnat Tirosh
Head of Microbiome Research and InnovationBiomicaJuan Basterra
CEOMikrobiomikShahram Lavasani
CEOImmuneBiotechDr. Shahram Lavasani is an international keynote speaker and entrepreneur in the field of the microbiome. He received his PhD in Immunology from Lund University/Sweden. With more than two decades of teaching and research expertise on Gut-Brain axis, he has pioneered research in multiple sclerosis by demonstrating gut inflammation and barrier dysfunction and introduced microbiota-based therapies using probiotic bacterial consortia. He is the founder of ImmuneBiotech developing novel microbiome therapeutics. The company has access to a proprietary lactobacilli library and advanced selection technologies to design nutritional formulations for optimal management of the diseases. ImmuneBiotech´s first product GutMagnific® has been designed to address the underlying causes of IBS and it is currently investigated, in collaboration with Karolinska Institute, for treatment of chronic fatigue syndrome (ME/CFS) a neuroimmune condition and a possible long-term effect of Covid-19. GutMagnific® has successfully been launched in October 2019.
Eric Van der Helm
VP Scientific Affairs, Bioinformatics & AutomationSNIPR BioAnna Chwalibog
CEO, Co-founderIntegral SolutionsEvelina Vågesjö, PhD MBA
CEOIlya PharmaCo-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.
Nathalie Corvaia
CSOMaaT PharmaChrysi Sergaki
Microbiome Group LeaderMHRASteve Emery
CSOChain BiotechSarah Lebeer
ProfessorUniversity of AntwerpRuben Vazquez Uribe
Co-principal InvestigatorNovo Nordisk Foundation Center for BiosustainabilityAdam Baker
Director of SciencesChr. HansenHarriet Schellekens
LecturerUniversity College CorkPilar Manrique Ronquillo
Research ScientistMicroviable TxRosanne Hertzberger
PIVrije Universiteit AmsterdamLothar Steidler
CTOActoBio TxJonathan Swann
ProfessorUniversity of SouthamptonSelin Bolca
Head of DevelopmentMRM HealthJohan E.T. van Hylckama Vlieg
Chief Scientific OfficerFreya BiosciencesChristophe Roca
Pilot Plant ManagerSacco SystemsStella Ackrell
VP, Pharmaceutical DevelopmentDestiny Pharma